Randomized, double-blind, double-dummy study of continuous infusion of levodopa-carbidopa intestinal gel in patients with advanced Parkinson's disease: Efficacy and safety

被引：0
|
作者：
Olanow, C. W.
Antonini, A.
Kieburtz, K.
Fernandez, H. H.
Espay, A. J.
Standaert, D. G.
Vanagunas, A. D.
Widnell, K. L.
Freeman, S.
Robieson, W. Z.
Pritchett, Y.
Chatamra, K.
Benesh, J.
Lenz, R. A.
机构：
来源：
MOVEMENT DISORDERS | 2012年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
411
引用
收藏
页码：S131 / S132
页数：2
相关论文
共 50 条
  • [21] Efficacy and safety of foslevodopa/foscarbidopa versus oral carbidopa/levodopa in advanced Parkinson's disease patients: Design of a phase 3, randomized, double-blind, double-dummy, active controlled 12-week trial
    Facheris, Maurizio
    Robieson, Weining
    Fisseha, Nahome
    Standaert, David
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429 : 331 - 331
  • [22] Long-Term Safety and Efficacy of Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson's Disease
    Fernandez, Hubert H.
    Boyd, James T.
    Fung, Victor S. C.
    Lew, Mark F.
    Rodriguez, Ramon L.
    Slevin, John T.
    Standaert, David G.
    Zadikoff, Cindy
    Vanagunas, Arvydas D.
    Chatamra, Krai
    Eaton, Susan
    Facheris, Maurizio F.
    Hall, Coleen
    Robieson, Weining Z.
    Benesh, Janet
    Espay, Alberto J.
    MOVEMENT DISORDERS, 2018, 33 (06) : 928 - 936
  • [23] Efficacy of levodopa-carbidopa intestinal gel compared to oral levodopa-carbidopa in advanced Parkinson's disease: Sensitivity and responder analyses
    Boyd, J. T.
    Fernandez, H. H.
    Slevin, J. T.
    Espay, A. J.
    Standaert, D. G.
    Pritchett, Y.
    Zhang, W.
    Chatamra, K.
    Widnell, K. L.
    Benesh, J.
    MOVEMENT DISORDERS, 2013, 28 : S143 - S143
  • [24] Jejunal Infusion of Levodopa-Carbidopa Intestinal Gel Versus Oral Administration of Levodopa-Carbidopa Tablets in Japanese Subjects with Advanced Parkinson's Disease: Pharmacokinetics and Pilot Efficacy and Safety
    Othman, Ahmed A.
    Chatamra, Krai
    Mohamed, Mohamed-Eslam F.
    Dutta, Sandeep
    Benesh, Janet
    Yanagawa, Masayoshi
    Nagai, Masahiro
    CLINICAL PHARMACOKINETICS, 2015, 54 (09) : 975 - 984
  • [25] Stable levodopa plasma levels with jejunal infusion of levodopa-carbidopa intestinal gel in advanced Parkinson's disease patients
    Nyholm, D.
    Odin, P.
    Johansson, A.
    Chatamra, K.
    Locke, C.
    Freeman, S.
    Dutta, S.
    Othman, A. A.
    MOVEMENT DISORDERS, 2012, 27 : S131 - S131
  • [26] Safety and efficacy of levodopa-carbidopa monotherapy in patients with advanced parkinson's disease
    Boyd, J. T.
    Zadikoff, C.
    Benesh, J. A.
    Zamudio, J.
    Robieson, W. Z.
    Kukreja, P.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 182 - 183
  • [27] Safety and Efficacy of Levodopa-Carbidopa Monotherapy in Patients with Advanced Parkinson's Disease
    Boyd, James
    Zadikoff, Cindy
    Benesh, Janet
    Zamudio, Jorge
    Robieson, Weining
    Kukreja, Pavnit
    NEUROLOGY, 2018, 90
  • [28] Safety and Efficacy of Levodopa-Carbidopa Monotherapy in Patients with Advanced Parkinson's Disease
    Boyd, James
    Zadikoff, Cindy
    Benesh, Janet
    Zamudio, Jorge
    Robieson, Weining
    Kukreja, Pavnit
    MOVEMENT DISORDERS, 2018, 33 : S87 - S88
  • [29] Safety and Efficacy of Levodopa-Carbidopa Monotherapy in Patients with Advanced Parkinson's Disease
    Boyd, J.
    Zadikoff, C.
    Siddiqui, M.
    Benesh, J.
    Zamudio, J.
    Robieson, W.
    Kukreja, P.
    MOVEMENT DISORDERS, 2018, 33 : S166 - S167
  • [30] Safety and Efficacy of Levodopa-Carbidopa Monotherapy in Patients With Advanced Parkinson's Disease
    Boyd, J.
    Zadikoff, C.
    Benesh, J.
    Zamudio, J.
    Robieson, W.
    Kukreja, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2018, 25 : 180 - 180
12345